AU2001270518A1 - Hypha-specific factors from candida albicans - Google Patents

Hypha-specific factors from candida albicans

Info

Publication number
AU2001270518A1
AU2001270518A1 AU2001270518A AU7051801A AU2001270518A1 AU 2001270518 A1 AU2001270518 A1 AU 2001270518A1 AU 2001270518 A AU2001270518 A AU 2001270518A AU 7051801 A AU7051801 A AU 7051801A AU 2001270518 A1 AU2001270518 A1 AU 2001270518A1
Authority
AU
Australia
Prior art keywords
contain
chips
hyphen
specific proteins
hypha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001270518A
Inventor
Franz-Josef Johannes
Steffen Rupp
Kai Sohn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fraunhofer Gesellschaft zur Forderung der Angewandten Forschung eV
Original Assignee
Fraunhofer Gesellschaft zur Forderung der Angewandten Forschung eV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fraunhofer Gesellschaft zur Forderung der Angewandten Forschung eV filed Critical Fraunhofer Gesellschaft zur Forderung der Angewandten Forschung eV
Publication of AU2001270518A1 publication Critical patent/AU2001270518A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/6895Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for plants, fungi or algae
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00Nanotechnology
    • Y10S977/70Nanostructure
    • Y10S977/788Of specified organic or carbon-based composition
    • Y10S977/789Of specified organic or carbon-based composition in array format
    • Y10S977/79Of specified organic or carbon-based composition in array format with heterogeneous nanostructures
    • Y10S977/791Molecular array
    • Y10S977/792Nucleic acid array, e.g. human genome array

Abstract

The present invention relates to biochips, in particular nucleotide chips, which contain hyphen-specific proteins coding nucleotides, protein chips which contain hyphen-specific proteins, and antibody chips which contain antibodies directed against these hyphen-specific proteins, diagnostic compositions which contain these nucleotide, protein, or antibody chips, processes for the location and identification of substances which are therapeutically effective against diseases caused by types of Candida and processes for the diagnosis of a disease caused by Candida.
AU2001270518A 2000-05-11 2001-05-10 Hypha-specific factors from candida albicans Abandoned AU2001270518A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10023130.6 2000-05-11
DE10023130A DE10023130B4 (en) 2000-05-11 2000-05-11 Hypha specific factors from Candida albicans
PCT/EP2001/005363 WO2001085989A2 (en) 2000-05-11 2001-05-10 Hypha-specific factors from candida albicans

Publications (1)

Publication Number Publication Date
AU2001270518A1 true AU2001270518A1 (en) 2001-11-20

Family

ID=7641684

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001270518A Abandoned AU2001270518A1 (en) 2000-05-11 2001-05-10 Hypha-specific factors from candida albicans

Country Status (8)

Country Link
US (1) US7220574B2 (en)
EP (1) EP1335936B1 (en)
AT (1) ATE340804T1 (en)
AU (1) AU2001270518A1 (en)
CA (1) CA2408634A1 (en)
DE (2) DE10023130B4 (en)
ES (1) ES2271040T3 (en)
WO (1) WO2001085989A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1622714A1 (en) * 2003-04-10 2006-02-08 PamGene B.V. Method for immobilizing biomolecules on metal oxide substrates
CN1948335B (en) * 2005-10-14 2010-05-12 中国科学院上海生命科学研究院 Candida albicans mycellium regulating and controlling factor gene and its use
US7745158B2 (en) 2005-12-14 2010-06-29 Kimberly-Clark Worldwide, Inc. Detection of secreted aspartyl proteases from Candida species
EP2887068B8 (en) 2013-12-20 2018-10-24 Bio-Rad Innovations Method for improving the diagnosis of invasive Candida infections by FBA1 protein detection

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5700636A (en) * 1990-10-19 1997-12-23 Becton Dickinson And Company Methods for selectively detecting microorganisms associated with vaginal infections in complex biological samples
CA2244891C (en) 1996-02-09 2008-12-30 Cornell Research Foundation, Inc. Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
AU4858597A (en) * 1996-10-30 1998-05-22 National Research Council Of Canada (candida albicans) proteins associated with virulence and hyphal formation and uses thereof
JP2002502038A (en) 1998-01-29 2002-01-22 ミラー,サミュエル High density arrays for proteome analysis and methods and compositions therefor
JP2002502977A (en) 1998-02-04 2002-01-29 インビトロジェン コーポレイション Microarrays and their uses
US6747137B1 (en) * 1998-02-13 2004-06-08 Genome Therapeutics Corporation Nucleic acid sequences relating to Candida albicans for diagnostics and therapeutics
DE60000836T2 (en) 1999-02-08 2003-09-04 Fuji Photo Film Co Ltd METHOD FOR PRODUCING A DNA CHIP
US6713255B1 (en) 1999-06-07 2004-03-30 Fuji Photo Film Co., Ltd. DNA chip, PNA chip, and their preparation methods
JP2001186881A (en) 1999-10-22 2001-07-10 Ngk Insulators Ltd Method for producing dna chip

Also Published As

Publication number Publication date
EP1335936B1 (en) 2006-09-27
ATE340804T1 (en) 2006-10-15
WO2001085989A8 (en) 2002-04-18
CA2408634A1 (en) 2001-11-15
WO2001085989A3 (en) 2003-06-05
DE10023130B4 (en) 2007-10-18
DE10023130A1 (en) 2001-11-22
DE50111112D1 (en) 2006-11-09
WO2001085989A2 (en) 2001-11-15
EP1335936A2 (en) 2003-08-20
WO2001085989A9 (en) 2003-09-12
US7220574B2 (en) 2007-05-22
ES2271040T3 (en) 2007-04-16
US20040014061A1 (en) 2004-01-22

Similar Documents

Publication Publication Date Title
IL145535A0 (en) Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases
ATA14642003A (en) VACCINE FOR THE ALZHEIMER DISEASE
WO2003016475A3 (en) Nucleic acid and amino acid sequences involved in pain
EP2292648A3 (en) Small Streptococcus pyogenes antigens and their use
EP2289544A3 (en) Peptides protective against S. pneumoniae and compositions, methods and uses relating thereto
EP2289907A3 (en) Streptococcus agalactiae antigens I + II
AU5328299A (en) Uses of the borreliacidal epitope(s) of borrelia burgdorferi outer surface protein c (ospc) as vaccine
WO2003093316A3 (en) Immunoglobulin-domain containing cell surface recognition molecules
ATE300619T1 (en) HUMAN CHECKPOINT KINASE, HCDS1, COMPOSITIONS AND METHODS
WO2004094476A3 (en) Compositions and methods relating to stop-1
WO2002059154A3 (en) Neutralizing human monoclonal antibodies against hiv-1, their production and uses
AU2001270518A1 (en) Hypha-specific factors from candida albicans
WO2003022298A3 (en) Use of a protein of the crmp family for treating diseases related to the immune system
EP1265073A3 (en) Methods for determining plasma free drug concentration
WO2005048822A3 (en) Antibodies and/or conjugates thereof which bind to the amino terminal fragment of urokinase, compositions and uses thereof
WO2004058986A3 (en) Btl-ii nucleic acids, proteins, and antibodies
WO2002070563A3 (en) Nuclear hormone receptor ligand binding domain
WO2007049065A3 (en) Vwfa, collagen and kunitz domain containing protein
WO2005019825A3 (en) Secreted polypeptide species and use thereof
WO2001014533A3 (en) Phosphomevalonate kinase (pmk) gene (erg8) from candida albicans
WO2002070558A3 (en) Nuclear hormone receptor ligand binding domain
WO2004009633A8 (en) Serotonin receptor
WO2002050116A3 (en) Adhesion molecule protein
WO2004000882A3 (en) Proteins
WO2001049839A3 (en) Method for expressing gene and use thereof